This map represents CDC’s largest funding categories for antibiotic resistance. It shows domestic, extramural funding that supports AR activities from multiple funding lines.
Laboratory & Diagnostics: Gold-standard lab capacity offered to all state and regional labs through CDC’s AR Laboratory Network
Epidemiology Capacity for Response: Increased capacity in state and local health departments for rapid detection and faster response to outbreaks and emerging resistance related to healthcare-associated infections, foodborne bacteria, and gonorrhea—to contain and control spread
Surveillance & Science: More effective prevention of healthcare-associated infections, foodborne illness, and gonorrhea
Improved Antibiotic Use: With partners, improve antibiotic use to ensure antibiotics work to protect patients from life-threatening infections or sepsis
Insights for Practice: With academic and healthcare partners, CDC is investing in innovations and collaborating with investigators to identify and implement new ways to prevent antibiotic-resistant infections and their spread
Research and Development: Sharing isolates that inform development of new drugs and diagnostics, and making public CDC’s sequencing data from AR pathogens to spur innovation in industry
To receive email updates about this page, enter your email address:
Antibiotic Resistance Investments - Version 1.10.00.01